Suchen
Tevogen Bio Holdings Inc
TVGNZur Watchlist hinzufügen
7.810USD
+0.380+5.11%
Handelsschluss 09-23 16:00（ET）
32.96MMarktkapitalisierung
VerlustKGV TTM
Über Tevogen Bio Holdings Inc Unternehmen
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Tevogen Bio Holdings Inc Profil
BörsenkürzelTVGN
Name des UnternehmensTevogen Bio Holdings Inc
IPO-datumNov 04, 2021
CEOSaadi (Ryan)
Anzahl der mitarbeiter18
WertpapierartOrdinary Share
GeschäftsjahresendeNov 04
Addresse15 Independence Boulevard, Suite #210
StadtWARREN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07059
Telefon16468078832
Websitehttps://tevogen.com/
BörsenkürzelTVGN
IPO-datumNov 04, 2021
CEOSaadi (Ryan)
Führungskräfte von Tevogen Bio Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
187.98K
-29.26%
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
187.98K
-29.26%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
121.28K
+61.84%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
121.28K
+61.84%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
121.28K
+61.84%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
121.28K
+61.84%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
--
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
--
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
187.98K
-29.26%
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
187.98K
-29.26%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
121.28K
+61.84%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
121.28K
+61.84%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
121.28K
+61.84%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
121.28K
+61.84%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Tevogen Bio Holdings Inc?
Die fünf größten Anteilseigner von Tevogen Bio Holdings Inc sind: Mr. Kirti Desai
Wie viele Institutionen halten Anteile an Tevogen Bio Holdings Inc (TVGN)?
Mit Stand vom 2026Q1 halten 115 Institutionen Anteile an Tevogen Bio Holdings Inc, mit einem Gesamtmarktwert von etwa 168.15K, was 4.02% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -44192.00 gestiegen.